FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/29/2026
Back to search
Official data from USPTO
ACELLYTRON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACELLYTRON
ST13
US500000079392046Class
5, 35, 42, 44
Filing
79392046
Registration
7830495
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 35, 42, 44
Filing date
11/28/2023
Registration date
06/17/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/17/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
CN
Examiner
THOMAS, JULIE
Law office
L70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Wuxi Biologics (Shanghai) Co., Ltd.
Representatives
Michael T. Smith Birch Stewart Kolasch & Birch LLP
Technical classification
Nice Classes
Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical-pharmaceutical preparations for the treatment of blood cancersolid tumorcancer or tumorautoimmune diseasenon-communicable diseasesNeurodegenerative diseasesaging-related diseasescoagulation disorder and infectious disease; biochemical medicines for the treatment of blood cancersolid tumorcancer or tumorautoimmune diseasenon-communicable diseasesNeurodegenerative diseasesaging-related diseasescoagulation disorder and infectious disease; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes for the treatment of blood cancersolid tumorcancer or tumorautoimmune diseasenon-communicable diseasesNeurodegenerative diseasesaging-related diseasescoagulation disorder and infectious disease; drugs for medical purposesnamely medicines for the treatment of blood cancersolid tumorcancer or tumorautoimmune diseasenon-communicable diseasesNeurodegenerative diseasesaging-related diseasescoagulation disorder and infectious disease; pharmaceutical preparations for the treatment of blood cancersolid tumorcancer or tumorautoimmune diseasenon-communicable diseasesNeurodegenerative diseasesaging-related diseasescoagulation disorder and infectious disease; drugs for treatment of cancer; medical preparation for treating diseases and disorders related to the immune system; biological agentnamely biologic preparations for treating cancer; pharmaceutical preparations for the prevention and treatment of cancer; living cells for medical use; oncolytic viral therapies; medical cell inhibitornamely proteinantibody and small molecule inhibitor; reagents for medical purposes; anticancer agent; diagnostic reagents for medical purposes; pharmaceutical preparationsnamely tumor suppressor; cells for medical use; dietetic food and substances adapted for medical use; biological preparations for veterinary purposes for the treatment of blood cancersolid tumorcancer or tumorautoimmune diseasenon-communicable diseasesNeurodegenerative diseasesaging-related diseasescoagulation disorder and infectious disease
Class 35
Online advertising on a computer network; advertising services; publicity agents; dissemination of advertising and advertising matter in the nature of flyersprospectusesbrochuresleaflets and samples; providing commercial information and advice for consumers in the choice of products and services; organization of exhibitions and trade fairs for commercial or advertising purposes; import-export agency services; marketing; sponsorship search; retail store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies
Class 42
Research and development of new products for others; technological research in the field of pharmaceutical studiescell separation and cell culture; chemical analysis; biochemistry research and analysis; research and development in the field of pharmaceutical preparations; medical research service; research and development services in the field of antibodies; stem cell research services; medical research; medical and scientific researchnamely conducting clinical trials for others; biological research; computer programming in the field of medical aspects
Class 44
Preparation of prescriptions by pharmacists; stem cell therapy services; medical clinic services; providing medical information; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; health care; medical assistance
Publications
History of USPTO decisions and trademark events.
31 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/14/2026
FIMP
FINAL DISPOSITION PROCESSED
01/14/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/17/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/05/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/20/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/20/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/17/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/17/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/29/2025
PUBO
PUBLISHED FOR OPPOSITION
04/29/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/23/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/21/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/21/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/13/2025
GNFR
FINAL REFUSAL E-MAILED
01/13/2025
CNFR
FINAL REFUSAL WRITTEN
01/13/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/10/2024
RFNT
REFUSAL PROCESSED BY IB
08/11/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/18/2024
RFRR
REFUSAL PROCESSED BY MPU
07/18/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/27/2024
CNRT
NON-FINAL ACTION WRITTEN
06/26/2024
DOCK
ASSIGNED TO EXAMINER
06/26/2024
MAFR
APPLICATION FILING RECEIPT MAILED
03/27/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/23/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/21/2024
Continuous trademark protection
Get notified about every new filing that threatens ACELLYTRON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.